Life sciences

In a time of uncertainty, venture capitalists are shifting from biotech to the lower-risk, lower-reward field of MedTech.

US genomics firm Myriad Genetics regains limited rights to BRCA1 breast cancer gene on final appeal.

Whether someone will become an entrepreneur may be down to whether they make risky decisions. And for those without this innate ability, teaching or drugs could help enhance entrepreneurial skills.